TrialBMJ open2023

Multicentre, randomised, double-blind, parallel controlled trial to investigate timing of platelet inhibition after coronary artery bypass grafting: TOP-CABG trial study.

Xin Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.